QTTB FY 2023 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$7M-200.0% YoY

Gross Profit

-$7M100.0% margin

Operating Income

-$48M725.5% margin

Net Income

-$54M808.0% margin

EPS (Diluted)

$-16.70

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$47M

Total Liabilities

$230M

Stockholders' Equity

-$183M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$7M	$7M	-200.0%
Gross Profit	-$7M	$7M	-200.0%
Operating Income	-$48M	-$39M	-23.0%
Net Income	-$54M	-$43M	-25.5%